Safety Shot Stock Price, News & Analysis

Safety Shot (NASDAQ: SHOT) announced that President Jordan Schur, through his family fund Core 4 Capital, invested an additional $3.4 million via a private placement on Sept. 4, 2024. The placement issued 3,370,787 shares at $0.89 and 3,370,767 warrants at $0.125. Core 4's cumulative investment in Safety Shot now totals $9.4 million, including $5.0 million raised in April and $1.0 million in June. The company said net proceeds will be used for working capital, general corporate purposes, and brand development. The release also references a clinical trial by the Center for Applied Health Sciences reporting the product lowers blood alcohol content and reduces next-morning symptoms of excessive drinking. The company will file a Form 8-K on Sept. 4, 2024 with full transaction details.

Safety Shot, Inc. (Nasdaq: SHOT) announced that its President, Jordan Schur, has invested an additional $3.4 million in the company through his family investment group, Core 4 Capital Corp. This investment comes in the form of a private placement, with the issuance of 3,370,787 shares at $0.89 per share and 3,370,767 warrants at $0.125 per warrant. Combined with previous investments, Core 4 has now invested a total of $9.4 million in Safety Shot.

Schur expressed enthusiasm about the company's progress, citing recent clinical trial results that demonstrate Safety Shot's effectiveness in lowering Blood Alcohol Content and alleviating hangover symptoms. The company plans to use the proceeds for working capital, general corporate purposes, and to support the growth of the Safety Shot brand.

Safety Shot, Inc. (Nasdaq: SHOT) has reported groundbreaking clinical results for its rapid alcohol reducer. The double-blind, randomized, placebo-controlled study showed that Safety Shot not only significantly decreases blood alcohol content (BAC) in as little as 30 minutes but also rapidly reduces acetaldehyde in the blood, the main cause of unpleasant after-effects from heavy drinking.

The study demonstrated a substantial increase in aldehyde dehydrogenase and a marked decrease in acetaldehyde, proving that Safety Shot can effectively remove alcohol-related toxins faster than the body's natural processes. This breakthrough addresses the root cause of morning-after symptoms, which is acetaldehydes, not dehydration.

Safety Shot's patented formula is available in a 12oz drink, 4oz shot, and dry powder stick pack, positioning the company as a leader in combating alcohol's negative effects.

Safety Shot, Inc. (Nasdaq: SHOT), the company behind the world's first alcohol detoxifier, has announced a partnership with VENDO, a leading e-commerce platform. This strategic move aims to significantly boost Safety Shot's online presence and brand growth. VENDO, known for its expertise in Amazon and Walmart marketplaces, will help Safety Shot navigate the rapidly expanding e-commerce landscape, which was valued at $6.9 trillion in 2024.

Safety Shot's President, Jordan Schur, expressed enthusiasm about the partnership, highlighting VENDO's reputation as the best team in the business. VENDO CEO Darren Saul emphasized their commitment to helping Safety Shot reach a wider audience through seamless online shopping experiences across various platforms.

Safety Shot, Inc. (Nasdaq: SHOT) reported strong Q2 2024 results, with a 40% increase in sales and a 17.7% decrease in operating expenses compared to Q1. The company's recent clinical trial demonstrated significant efficacy in reducing Blood Alcohol Content (BAC), showing a 30%-50% faster rate of alcohol reduction within 30 minutes of consumption compared to placebo.

Safety Shot announced new product formats, including 4-ounce bottles launching in Q3 and a powdered version in Q4. The company also secured partnerships with Capital Drugs, expanding to 300 pharmacies nationwide, and Mr. Checkout for wider distribution. Additional partnerships include GoPuff and BevMo, enhancing market presence.

Safety Shot, Inc. (Nasdaq: SHOT) has announced significant findings from a recent clinical trial conducted at The Center for Applied Health Sciences. The study evaluated the impact of Safety Shot on Blood Alcohol Content (BAC) and demonstrated remarkable results. Within 30 minutes of consuming Safety Shot, participants showed a 30%-50% faster rate of alcohol reduction compared to the placebo group.

Key findings include:

• Consistent lowering of breath alcohol content
• Significant improvements in BAC, ethanol, acetaldehyde, and aldehyde dehydrogenase levels
• Reduced head discomfort, fatigue, and improved concentration

The study results are being prepared for peer review and publication in a biomedical journal. Safety Shot aims to revolutionize the wellness space with its innovative approach to responsible alcohol consumption.

Safety Shot, Inc. (Nasdaq: SAFS) is set to launch a powdered version of its alcohol-reducing product in early Q4. The new format, available in convenient stick packs, maintains the full efficacy of the original formula. This innovation addresses a growing market for stick packaging solutions, projected to reach $517.61 million by 2031.

The powder stick packs will be sold in packs of 6, with single stick options available at select locations. This format expansion aims to increase brand visibility, broaden the customer base, and offer greater convenience for consumers looking to reduce their blood alcohol content in as little as 30 minutes.

Safety Shot, Inc. (Nasdaq: SHOT) is set to launch a powdered version of its alcohol-reducing nutraceutical in early Q4. The product, available in convenient stick pack format, maintains 100% efficacy of the original formula. This expansion addresses the growing global stick packaging market, projected to reach $517.61 million by 2031.

The powder stick packs will be offered in packs of 6, with some locations providing single stick options. This new format aims to increase brand visibility, expand retail presence, and broaden the customer base. Safety Shot's innovative product is designed to reduce blood alcohol content in as little as 30 minutes, offering a portable solution for consumers on the go.

Safety Shot, Inc. (Nasdaq: SHOT) has announced a strategic partnership with KeHE Distributors, a leading natural and organic food distributor in North America. This collaboration aims to expand Safety Shot's nationwide presence and enhance consumer accessibility. KeHE's network of over 6,800 employee-owners and 19 distribution centers will help deliver Safety Shot's products to thousands of new retail locations across the United States.

Josh Wager, Safety Shot's Chief Revenue Officer, expressed excitement about the partnership, highlighting its potential to bring Safety Shot to a broader audience. This distribution milestone follows recent partnerships with Atlantic Beverage Distributors and Prime CSB, further expanding Safety Shot's market reach to meet increased demand.